For each HLRCC or SDHB-RCC primary kidney tumor the number of these probes where the β-value was greater than 0.5 was calculated and used as a representative level of hypermethylation (S6 Table). The gene discussed is SDHB; the disease is hereditary leiomyomatosis and renal cell cancer.